SHASUN PHARMACEUTICALS LIMITED - CONSOLIDATED FIRST QUARTER RESULTS - Q1 FY 2013 - NET SALES Rs.250 Cr ( agnst Rs.192 Cr in Q1 FY 12); NPT Rs.14 cr (agnst Rs.7 Cr in Q1 FY 12)

SHASUN PHARMACEUTICALS LIMITED

CONSOLIDATED FIRST QUARTER RESULTS

Q1 FY 2013

SHASUN PHARMA has declared its consolidated results for Q1 FY 2013. The High lights of the same are as below :

NET SALES for Q1 FY 13 stand at Rs.249.99 Cr compared to the previous qtr (Q4 FY 12) amount of Rs.288.72 Cr; and compared to the Q1 FY 12 amount of Rs.192.21 cr. The total amount for FY 12 was Rs.1014.92 cr.

The Total Income for Q1 FY 13 stands at Rs.265.60 Cr; against Rs.305.53 Cr for Q4 FY 12; Rs.200.82 cr for Q1 FY 12 and Rs.1066.40 Cr for FY 12.

Total expenses amount to Rs.244.48 Cr for Q1 FY 13; Rs.271.21 Cr for Q4 FY 12; Rs.193.35 Cr for Q1 FY 22; and Rs.983.98 Cr for FY 12.

Profit from Operations stands at  Rs.21.12 cr for Q1 FY 13; Rs.34.32 Cr for Q4 FY 12; Rs.7.47 Cr for Q1 FY 12 and Rs.82.42 Cr for FY 12.

PBT stands at Rs.13.83 Cr in Q1 FY 13;Rs.61.78 Cr in Q4 FY 12; Rs.7.16 Cr in Q1 FY 12; and Rs.79.64 Cr in FY 12.

Net Profit stands at Rs.13.82 cr for Q1 FY 13; Rs.58.98 cr for Q4 FY 12; Rs.6.83 Cr for Q1 FY 12; and Rs.100.57 cr for FY 12

EPS (On FV of Rs.2) amounts to Rs.2.44 for Q1 FY 13; Rs.11.74 for Q4 FY 12; Rs.1.41 for Q1 FY 12; and Rs.20.39 for FY 12.

 *  *  *  E  P  S  *  *  *